Authors
Loading...
Retrospective analysis highlights low efficacy of standard lipid-lowering therapy in patients with chronic coronary syndromes, suggesting need for personalized approaches.
Filina et al. (2025) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: